SCHEMBL5999728

SCHEMBL5999728

C=CCn1c(CN(CC(=O)O)Cc2ccc(-c3ccc(COc4ccc(C(CCC)CCC)cc4)cc3)s2)nc2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN2 P17706 1/20 0.49
PTPN1 P18031 1/20 0.49
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
PPARA Q07869 3/20 0.41
FFAR1 O14842 1/20 0.41
MAPK1 P28482 1/20 0.38
PPARG P37231 2/20 0.36
TP53 P04637 3/20 0.36
MAPT P10636 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD17B10 Q99714 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CCR5 P51681 1/20 0.35
PKM P14618 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6001102 0.90 PTPN2 (0.49) PTPN2PTPN1PPARAPPARGTP53
SCHEMBL5999254 0.89 PTPN2 (0.52) PTPN2PTPN1NPC1RAB9APPARA
SCHEMBL6000673 0.82 PTPN2 (0.45) PTPN2PTPN1NPC1RAB9APPARG
SCHEMBL6000512 0.82 PTPN2 (0.46) PTPN2PTPN1NPC1RAB9APPARA
SCHEMBL6000441 0.82 PTPN2 (0.44) PTPN2PTPN1NPC1RAB9APPARA
SCHEMBL5999082 0.81 PTPN2 (0.54) PTPN2PTPN1PPARAFFAR1PPARG
SCHEMBL6000614 0.80 PTPN1 (0.51) PTPN2PTPN1NPC1RAB9APPARA
SCHEMBL6000866 0.79 PTPN1 (0.52) PTPN2PTPN1PPARAFFAR1PPARG
SCHEMBL6000625 0.78 PTPN2 (0.54) PTPN2PTPN1PPARAFFAR1PPARG
SCHEMBL6000456 0.78 PTPN2 (0.52) PTPN2PTPN1NPC1RAB9APPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US claimed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP claimed
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 PTPN2 11/4885PTPN1 2/4885NPC1 955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.